Alireza Nikoofar Selected Research

Alireza Nikoofar Research Topics

13	Neoplasms (Cancer) 09/2022 - 05/2012
6	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2014
2	Sensorineural Hearing Loss 04/2020 - 12/2017
2	Bipolar Disorder (Manic Depressive Psychosis) 05/2014 - 01/2014
1	Lung Neoplasms (Lung Cancer) 09/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022
1	Mouth Neoplasms (Oral Cancer) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2017
1	Hearing Loss (Hearing Impairment) 07/2015
1	Ototoxicity 07/2015
1	Deglutition Disorders (Dysphagia) 05/2015
1	Brain Neoplasms (Brain Tumor) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 12/2014
1	Glioma (Gliomas) 01/2014
1	Glioblastoma (Glioblastoma Multiforme) 01/2014
1	Hypothyroidism 02/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2012
1	Spinal Cord Diseases 05/2005

3	Estrogen ReceptorsIBA 12/2016 - 07/2015
3	Pharmaceutical PreparationsIBA 05/2014 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 04/2020 - 07/2015
2	Lithium ChlorideIBA 05/2014 - 01/2014
1	buteinIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	FlavonoidsIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Dental Implants (Dental Implant)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	phytobacteriomycin (PBM)IBA 12/2017
1	Radiation-Sensitizing AgentsIBA 12/2017
1	2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA 12/2016
1	PolyphenolsIBA 12/2016
1	BromidesIBA 03/2016
1	caffeic acid phenethyl esterIBA 03/2016
1	daidzeinIBA 07/2015
1	EquolIBA 07/2015
1	IsoflavonesIBA 07/2015
1	GlucansIBA 12/2014
1	LithiumIBA 05/2014
1	GossypolIBA 01/2014
1	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2013
1	ProstaglandinsIBA 05/2005